Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.55	5.17	3.69	6.58	25.91	27.33
Cash & Short-Term Investments	1.55	5.17	3.69	6.58	25.91	27.33
Cash Growth	-70.92%	39.99%	-43.89%	-74.61%	-5.18%	66.63%
Accounts Receivable	10.89	16.07	13.9	15.75	16.12	22.67
Other Receivables	0.43	0.52	1.52	1.83	1.54	3.09
Total Trade Receivables	11.32	16.58	15.42	17.59	17.66	25.75
Inventory	20.13	19.37	19.93	22.5	29.12	30.22
Total Current Assets	33	41.12	39.04	46.67	72.69	83.3
Net Property, Plant & Equipment	4.31	4.62	1.89	5.68	5.92	8.55
Goodwill	55.92	51.34	16.27	35.27	35.98	33.86
Long-Term Investments	-	2.46	-	-	-	-
Other Long-Term Assets	2.86	3.75	2.23	4.49	4.31	4.69
Total Assets	99.63	103.29	59.44	92.1	118.9	130.4
Accounts Payable	26.49	26.78	12.8	15.38	15.13	24.34
Short-Term Debt	0.21	0.21	0.21	0.21	83.31	-
Current Portion of Leases	2.3	2.29	1.69	1.68	1.98	2.15
Other Current Liabilities	2.53	2.82	0.33	0.08	0.07	0.57
Total Current Liabilities	31.52	32.1	15.04	17.34	100.49	27.06
Long-Term Debt	99.5	87.79	54.65	58.05	-	82.7
Long-Term Leases	10.55	10.48	10.87	12.27	13.87	16.59
Other Long-Term Liabilities	7.59	8.11	2.83	6.63	4.86	6.28
Total Long-Term Liabilities	117.65	106.38	68.35	76.94	18.72	105.56
Total Liabilities	149.17	138.47	83.38	94.28	119.21	132.62
Common Stock	4.34	4.19	1.97	1.96	1.21	1.21
Treasury Stock	-24.92	-24.92	-24.92	-24.92	-24.92	-24.92
Additional Paid-in Capital	70.51	70.11	53.33	53.17	16.19	16.19
Accumulated Other Comprehensive Income	-5.8	-5.44	-5.68	-5.69	-5.36	-5.27
Retained Earnings	-93.66	-114.3	-72.59	-28.87	12.24	8.35
Shareholders' Equity	-49.54	-70.36	-47.9	-4.35	-0.64	-4.44
Total Liabilities & Equity	99.63	103.29	59.44	92.1	118.9	130.4
Total Debt	112.56	100.76	67.43	72.2	99.16	101.44
Net Cash (Debt)	-111.01	-95.6	-63.74	-65.62	-73.25	-74.11
Net Cash Per Share	-2.13	-5.32	-8.33	-9.73	-17.52	-88.64
Book Value	-49.54	-70.36	-47.9	-4.35	-0.64	-4.44
Book Value Per Share	-0.95	-3.92	-6.26	-0.65	-0.15	-5.31
Tangible Book Value	-105.46	-121.71	-64.17	-39.62	-36.62	-38.3
Tangible Book Value Per Share	-2.02	-6.78	-8.38	-5.87	-8.76	-45.81

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q